Category:

Non-Life

Overall COVID-19 seropositivity among healthcare workers over 25 per cent: minister

The Indian Council of Medical Research is undertaking periodic sero-surveillance to monitor the trend of COVID-19 infection. As per the third seroprevalence study (December 2020 to January 2021) results the overall COVID-19 seropositivity among healthcare workers is assessed to be 25.7 per cent,” he said in a written reply. Seroprevalence is highest among doctors and nurses (26.6 per cent), followed by para-medical staff (25.4 per cent), field staff (25.3 per cent) and administrative staff (24.9 per cent), Choubey said in a written reply.

read more

WHO says coronavirus unlikely to have leaked from China lab

The WHO team’s mission is intended to be an initial step delving into the origins of the virus, which is believed to have originated in bats before being passed to humans through another species of wild animal, such as a pangolin or bamboo rat, which is considered an exotic delicacy by some in China.

Transmission through the trade in frozen products was also a possibility, WHO food safety and animal diseases expert Peter Ben Embarek said.

read more

IRDAI asks insurers to promote Govt’s Digilocker for e-storing their policy documents

Digilocker is an initiative under the Digital India program by the Government of India where citizens can get authentic documents/ certificate in digital format from original issuers of these certificates.
The insurers should inform their retail policyholders about Digilocker and how to use it. Insurers are also advised to enable the process by which the policyholders can place their policies in the digilocker., said the IRDAI.

I

read more

A few Covid vaccine recipients developed a rare blood disorder

It is not known whether this blood disorder is related to the Covid vaccines.

More than 31 million people in the United States have received at least one dose, and 36 similar cases had been reported to the government’s Vaccine Adverse Event Reporting System, VAERS, by the end of January. The cases involved either the Pfizer-BioNTech or Moderna vaccine, the only two authorized so far for emergency use in the United States.

read more